Merck has applied for emergency authorization for experimental COVID pill
chinadaily.com.cn | Updated: 2021-10-13 07:50
Merck and Ridgeback Biotherapeutics announced on Monday that they have applied to US healthcare regulators for emergency use authorization for their joint anti-coronavirus pills. A five-day course of eight pills a day, totaling 40 pills and taken orally, costs about $700.
Editor's Pick
